Sysmex CC-130
by Toa Medical Electronics USA, Inc.
510(k) K830505
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK830505 | Date9 May 1983 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GKL
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.5200
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Sysmex CC-130 is an automated particle counter used in hematology for counting cells. It is classified as a Class II medical device under FDA regulation 864.5200 with product code GKL.
The device received traditional 510(k) clearance (K830505) from Toa Medical Electronics USA, Inc. on May 9, 1983, and is substantially equivalent to a legally marketed predicate device. It is supplied as a reusable instrument for use in clinical laboratory settings.
Other devices from Toa Medical Electronics USA, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the Sysmex CC-130 used for?
The Sysmex CC-130 is an automated particle counter used in hematology for counting cells in clinical laboratory settings, as specified in its device description and classification under FDA regulation 864.5200.
Is the Sysmex CC-130 reusable or single-use?
The Sysmex CC-130 is supplied as a reusable instrument, meaning it is designed for multiple uses in clinical laboratory environments after appropriate cleaning and maintenance, as stated in the device data.
How was the Sysmex CC-130 cleared for market?
The Sysmex CC-130 received traditional 510(k) clearance (K830505) from the FDA on May 9, 1983, demonstrating substantial equivalence to a legally marketed predicate device, which is the regulatory pathway described in the authorization details.